Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:IMR) ).
Imricor Medical Systems has secured firm commitments to raise A$60 million through a placement of 32.4 million new CHESS Depositary Interests to institutional and sophisticated investors at A$1.85 per CDI, a modest discount to recent trading prices. The raise, which leaves the company with an expected A$102.9 million in cash after costs, strengthens its balance sheet and positions it to scale its interventional MR platform globally.
The company plans to deploy the funds to launch its NorthStar system in the U.S., pursue full regulatory approvals for its electrophysiology platform, and support a broader commercial rollout from 2027 targeting hospitals with existing and new CMR facilities. Proceeds will also finance key clinical trials in Europe and the U.S., advance Pulsed Field Ablation technology for atrial fibrillation, expand its product portfolio and Middle East presence, and accelerate NorthStar development beyond cardiology applications, underpinning Imricor’s shift from momentum to larger-scale commercialisation.
The most recent analyst rating on (AU:IMR) stock is a Buy with a A$2.63 price target. To see the full list of analyst forecasts on Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:IMR Stock Forecast page.
More about Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Imricor Medical Systems, Inc. is a medical technology company focused on developing interventional cardiac electrophysiology solutions designed for use in MRI environments. The company targets hospitals with cardiac magnetic resonance (CMR) facilities, including paediatric centres, and is building a comprehensive electrophysiology platform and related interventional tools for global markets.
Average Trading Volume: 323,908
Technical Sentiment Signal: Buy
Current Market Cap: A$633.9M
For detailed information about IMR stock, go to TipRanks’ Stock Analysis page.